Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
HUM · NYSE · Healthcare
Fundamental quality
32
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its financial strength weighs in its favor, while its growth drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $83,064M | $2,933M | $920M | $9,100M |
| 2022 | $92,870M | $2,806M | $3,450M | $6,065M |
| 2023 | $106,374M | $2,489M | $2,977M | $6,962M |
| 2024 | $117,761M | $1,207M | $2,391M | $9,500M |
| 2025 | $129,664M | $1,188M | $375M | $8,169M |
Between 2021 and 2025, revenue went from $83,064M to $129,664M (+56%) and net income went from $2,933M to $1,188M (-59%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Humana Inc a profitable company?
Humana Inc is profitable, with a net margin of 0.8%, though a thin one.
Does Humana Inc have a lot of debt?
A moderate level: its net debt is 2.9 times its EBITDA.
Is Humana Inc growing?
Its revenue has grown 12.8% annualized in recent years.
Does Humana Inc generate cash?
Yes. It converts about 0.9% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Humana Inc cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →